Wojciech Matusik is a Professor of Electrical Engineering and Computer Science at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL). He leads the Computational Design and Fabrication Group and is a member of the Computer Graphics Group. His research spans computer graphics, robotics, and AI-driven manufacturing, with a focus on computational design, tactile sensing, and material science. Matusik holds a PhD in Computer Science from MIT (2003), an MS from MIT (2001), and a BS from UC Berkeley (1997). His work includes groundbreaking projects like differentiable cloth simulation (DiffCloth), AI-enhanced molecular design, and tactile sensing gloves. He has received prestigious awards such as the MIT TR35 (2004), DARPA Young Faculty Award (2012), and Ruth and Joel Spira Teaching Award (2014). Matusik teaches courses on computer graphics, machine learning, and computational fabrication at MIT. Key research themes include: Robotics: Robotic assembly, tactile interaction, and soft robotics Graphics: 3D holography, procedural material generation Manufacturing: Additive fabrication, topology optimization His recent articles explore AI-driven molecular synthesis, holographic displays, and tactile-enabled VR systems. Matusik collaborates on open-source tools like the WiReSens tactile platform and Simit language for sparse systems.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۲۸۷ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
- 3D Printing
- Nanotechnology
- Biomedical Engineering
- +۴ مورد دیگر
Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Connor Coleyمشاهده پروفایل
استادیار
Connor Coley is the Henri Slezynger (1957) Career Development Assistant Professor at the Massachusetts Institute of Technology (MIT) School of Engineering. His research bridges chemistry and machine learning, focusing on autonomous molecular discovery, predictive chemistry, and laboratory automation. Education: Ph.D., MIT (2019) M.S.CEP., MIT (2016) B.S., Caltech (2014) Research Interests: Dr. Coley’s work centers on domain-informed machine learning for chemistry, computer-aided molecular design, and autonomous laboratories. Key themes include predictive modeling of chemical reactivity, optimization of synthesis pathways, and integration of AI with experimental data for drug discovery and materials science. Publications: His recent articles highlight advancements in AI-driven reaction prediction, molecular representation learning, and laboratory automation. Trends include applications of Bayesian optimization, contrastive learning, and diffusion models to chemical discovery. Scientific Awards: Camille Dreyfus Teacher-Scholar Award (2025) James W. Swan Outstanding Faculty (2025) Schmidt Futures AI2050 Early Career Fellow (2022) NSF CAREER Award (2021) Forbes 30 Under 30: Healthcare (2019) Software & Tools: He leads the open-source ASKCOS software suite for synthesis planning, adopted by 35,000+ chemists and deployed at 15+ pharmaceutical companies. His team also develops tools for metabolomics and molecular representation learning.
Levent Burak Kara is a Professor in the Department of Mechanical Engineering at Carnegie Mellon University (CMU), with a courtesy appointment in the Robotics Institute. He is a leading researcher in AI-driven computational design, additive manufacturing, and intelligent engineering systems, leading the Visual Design and Engineering Lab (VDEL) at CMU. Education: B.S., Mechanical Engineering, Middle East Technical University (1998) M.S., Mechanical Engineering, Carnegie Mellon University (2000) Ph.D., Mechanical Engineering, Carnegie Mellon University (2005) His research focuses on integrating machine learning, optimization, and geometric modeling to revolutionize engineering design and manufacturing. Key areas include topology optimization, CAD intelligence, digital twins, generative design, bioengineering, and electronic design automation. His work enables automation of traditionally labor-intensive design processes using deep learning and reinforcement learning. His recent publications reveal a strong trend toward physics-informed surrogate modeling, real-time simulation, manufacturability prediction, and AI-driven automation in mechanical, biomedical, and electronic systems. These works frequently appear in top journals such as Journal of Mechanical Design and Journal of Applied Mechanics , and at premier conferences like NeurIPS and DAC. Scientific Awards: National Science Foundation CAREER Award ASME Design Automation Society Young Investigator Award Google AI for Social Good Impact Scholar Kara advises several Ph.D. students and has secured significant funding from federal agencies such as the NSF and the U.S. Army Research Laboratory, as well as collaborations with industrial leaders including Cadence Design Systems and NVIDIA. His research is also supported by CMU’s NextManufacturing Center and the Critical Technology Initiative. He is actively involved in developing intelligent design systems that leverage AI to automate product design, optimize manufacturing processes, and improve medical diagnostics, particularly in oral cancer screening and organ preservation. His lab, VDEL, is a hub for innovation in AI-enabled engineering.
Outi Salo-Ahenمشاهده پروفایل
مدرس ارشد
Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.
- Drug Design
- Molecular Modeling
- Anti-Cancer Drugs
- +۳ مورد دیگر
Antti Poso is a Professor of Drug Design at the University of Eastern Finland (Kuopio), affiliated with the School of Pharmacy under the Faculty of Health Sciences. His research focuses on computer-aided molecular design, particularly targeting anti-cancer drugs and anti-microbials. Key projects include the EDCMET project (2019–2024) and the GeneCellNano Flagship (2020–2028). He leads the Molecular Modeling and Drug Design Research Group, specializing in QSAR analysis, kinase inhibition profiling, and systems-level drug response modeling. Recent work includes studies on SARS-CoV-2 inhibitors, endocrine disruptors, and bacterial pathogenesis. His findings bridge chemical structure with biological outcomes, leveraging computational tools like CCA and molecular dynamics simulations. Collaborations span medicinal chemistry, pharmacology, and systems biology, contributing to both academic and applied drug discovery efforts. Education: Not explicitly stated in texts; assumed to hold advanced degrees in pharmacy or chemistry. Research Themes: Drug design, molecular modeling, QSAR, computational biology, and anti-infective agents. Key Contributions: Over 150+ publications, including influential works on chemoinformatics-driven drug response analysis and structure-based inhibitor design. Publications highlight advancements in kinase inhibitors, anti-microbial strategies, and viral hijacking mechanisms. His work emphasizes translating computational insights into therapeutic solutions for cancer, infectious diseases, and metabolic disorders.
Pia Vogel is a Professor in the Department of Biological Sciences at Southern Methodist University (SMU), where she leads research on nucleotide-binding proteins using Electron Spin Resonance spectroscopy and molecular modeling. Her work focuses on elucidating structural mechanisms in ATP synthase, multidrug resistance transporters, and calcium channels with biomedical applications in cancer therapy and neurodegenerative diseases. Education: Ph.D., University of Kaiserlautern Dr. Vogel's research program investigates three interconnected domains: the rotary mechanics of FoF1-ATP synthase (particularly the external stalk subunit b-dimer), the structural basis of multidrug resistance in P-glycoprotein and MRPs, and ATP-regulated calcium release via ryanodine receptors. Her laboratory employs site-specific spin labeling, ESR spectroscopy, and computational modeling to resolve protein dynamics and interactions at molecular resolution, contributing to understanding energy transduction in ATP synthase and mechanisms of drug resistance. Analysis of her 15 most recent publications (2020-2025) reveals a dominant focus on developing and characterizing P-glycoprotein and BCRP inhibitors to overcome chemotherapy resistance in cancer. These studies integrate computational screening, ATPase assays, and cell-based models to evaluate inhibitor efficacy, with emerging applications in Alzheimer's research through amyloid-β transport studies. The work demonstrates consistent methodological synergy between biophysical characterization and therapeutic development. Dr. Vogel maintains an active research group supported by sustained funding, evidenced by continuous publication output and laboratory infrastructure. Her team employs multidisciplinary approaches spanning biophysics, biochemistry, and computational biology to address fundamental questions in membrane protein function. Her laboratory facilities in DLSB 221 include specialized Electron Spin Resonance instrumentation and dual Linux computing clusters for molecular dynamics simulations. The research environment supports collaborative projects extending her work into cancer therapeutics and neurodegenerative disease mechanisms through partnerships with clinical and computational researchers.
Kate Farrahiمشاهده پروفایل
دانشیار
- Machine Learning
- Digital Health
- Human Sensing
- +۳ مورد دیگر
Dr. Kate Farrahi is an Associate Professor in the ECS department at the University of Southampton, where she leads research in the Vision, Learning and Control (VLC) Group. Previously, she was a Research Assistant at the Idiap Research Institute and earned her PhD in Computer Science from the Swiss Federal Institute of Technology in Lausanne (EPFL). Her work focuses on the intersection of machine learning and digital health, particularly in developing human sensing methods using vision and wearable technologies. She currently supervises four PhD students in Computer Science and actively accepts new PhD applications. Her research interests span machine learning applications in healthcare, including wearable device analytics, epidemiological modeling via AI, and drug discovery through generative methods. She has been recognized with a Best Paper Award (2022) and contributes to interdisciplinary research groups such as the Institute for Life Sciences and Centre for Machine Intelligence. Her work bridges computational methods with real-world health challenges, emphasizing practical deployment of AI solutions in clinical and public health contexts. Research Groups: Vision, Learning and Control; Institute for Life Sciences; Centre for Health Technologies; Centre for Machine Intelligence Key Collaborations: Cross-disciplinary projects combining computer science with biomedical engineering and public health
Ed E. Moretمشاهده پروفایل
دانشیار
- Antibodies
- Bioinformatics
- Cheminformatics
- +۷ مورد دیگر
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.
Meeyoung Cha is a Professor at KAIST and Scientific Director of the Max Planck Institute for Security and Privacy (MPI-SP) in Bochum, Germany. Her research focuses on Data Science for Humanity, encompassing computational social science, misinformation dynamics, and human-machine interaction. She holds a PhD in Computer Science from KAIST (2008) and previously served as Chief Investigator at the Institute for Basic Science and Visiting Professor at Facebook. Her work addresses societal challenges such as poverty mapping, fraud detection, and AI ethics. Key achievements include best paper awards and recognition like the Hong Jin-Ki Creator Award (2024) and Test-of-Time Awards (ACM IMC 2022, AAAI ICWSM 2020). Research interests span AI ethics, social media analysis, and interdisciplinary applications of machine learning. Notable projects include modeling climate risks via satellite imagery and analyzing chatbot interactions' societal impacts. She leads the MPI-SP's Data Science for Humanity Group, mentoring over 20 students across PhD and postdoc programs. Education: PhD in Computer Science (KAIST, 2008) Affiliations: MPI-SP (Germany), KAIST Key Awards: Hong Jin-Ki Creator Award, Korean Young Information Scientist Award, Test-of-Time Awards Her publications bridge computational methods with societal issues, including climate modeling, protein engineering, and algorithmic fairness. Current projects explore geospatial AI for economic development and ethical AI design frameworks.
Professor Thierry Langer is a Full Professor of Pharmaceutical Chemistry at the University of Vienna’s Faculty of Life Sciences (Department of Pharmaceutical Sciences). He leads research in computational drug design, with a focus on pharmacophore modeling, 3D-QSAR analysis, and AI-driven molecular design. His work bridges theoretical and experimental chemistry, addressing targets like viral proteases (e.g., SARS-CoV-2), GABA receptors, and dopamine transporters. Research interests include: Pharmacophore-guided drug discovery for anti-viral and CNS therapies Development of next-generation computational tools (e.g., PharmacoMatch, QPhAR) Protein-ligand interaction modeling using neural networks and graph-based algorithms Recent studies focus on: Inhibitors for herpesvirus nuclear egress complexes, AI-optimized antivirals, and dopamine transporter inhibitors for cognitive enhancement. His lab collaborates on projects like the NeuroDeRisk initiative to de-risk neurotoxic compounds. Publications emphasize drug repurposing, metabolic pathway analysis, and scalable synthesis methods for promising drug candidates.
Nuno Miguel Fonseca Ferreira is a Full Professor at the Instituto Superior de Engenharia de Coimbra (ISEC), part of the Polytechnic of Coimbra, where he currently serves as President of the Scientific Council. His academic career spans over 25 years at ISEC, progressing from Assistant to Professor Coordenador Principal. He has held significant leadership positions including Vice-President of ISEC (2001-2005), Pro-President of the Polytechnic of Coimbra (2009-2010), President of ISEC (2010-2013), and Vice-President of the Polytechnic of Coimbra (2013-2017), where he was responsible for internationalization initiatives. His educational background includes a degree in Electrical Engineering from the University of Porto (1996), a Doctorate in Electrical Engineering from the University of Trás-os-Montes and Alto Douro (2006), and a Habilitation Title (Aggregation) from the same institution (2020). His research focuses on Robotic Systems, with specialization in cooperative robotic systems as evidenced by his Habilitation work. Professor Ferreira's research spans multiple domains of robotics and intelligent systems, with particular emphasis on multi-robot coordination, environmental applications, and medical robotics. His work bridges theoretical control systems with practical applications across diverse fields including forestry, healthcare, manufacturing, and education. He has developed innovative approaches to robotic manipulation, sensor integration, and human-robot interaction, often incorporating advanced techniques from artificial intelligence and machine learning. His recent publications demonstrate a strong trend toward practical applications of robotics in real-world environments, particularly in forestry maintenance, industrial automation, and medical applications. The research shows progression from theoretical control systems to applied robotics in challenging environments, with increasing integration of computer vision, deep learning, and collaborative systems. His work spans both fundamental robotics research and immediate industrial applications, reflecting a balance between academic inquiry and practical implementation. Professor Ferreira has supervised two doctoral theses and participated in numerous research projects with substantial funding. His leadership extends to coordinating 15 of the 33 national and international R&D projects he has participated in, demonstrating significant grant acquisition and management capabilities. His international collaborations through Erasmus+ and other European programs highlight his role in fostering global research partnerships. He is an integrated member of GECAD (Research Group in Engineering and Intelligent Computing for Innovation and Advanced Development), a Portuguese R&D unit classified as Excellent by the Portuguese Science and Technology Foundation. Additionally, he is a member of LASI (Associated Laboratory for Intelligent Systems), the Portuguese laboratory associated with Artificial Intelligence, connecting him to a broader national research ecosystem.
Prof. Andreas Bender is a Professor for Machine Learning in Medicine at the Department of Medicine, Khalifa University, Abu Dhabi. He focuses on integrating heterogeneous chemical, biological, and medical data for clinically relevant decision-making. PhD, University of Cambridge Diplom-Chemiker, University of Frankfurt His research interests include Drug Discovery , Artificial Intelligence , Cheminformatics , and Computational Biology , particularly in the context of life science data analysis and AI/ML applications. He has been involved in founding biotech companies such as Healx Ltd., PharmEnable Ltd., and Pangea Bio. His work bridges academic research and translational drug discovery, with a focus on in silico methods and solubilizing difficult-to-drug targets.
Xuesen Dongمشاهده پروفایل
دانشیار
Dr. Xuesen Dong is an Associate Professor in the Department of Urologic Sciences at the University of British Columbia and a senior scientist at the Vancouver Prostate Centre. His research focuses on prostate cancer therapy resistance mechanisms and developing novel therapeutics. His educational background: Medical training in China MSc in Molecular and Cellular Biology, Laval University PhD in Physiology, University of Toronto Postdoctoral training: Samuel Lunenfeld Research Institute (Mount Sinai Hospital, University of Toronto) and Vancouver Prostate Centre Research interests include prostate cancer, therapy resistance, RNA splicing, gene regulation, drug development, hormone-dependent cancers, endocrine regulation, and biomarker discovery. His lab uses RNA sequencing and computer-aided drug design to identify new targets and diagnostics for prostate cancer. Scientific awards and funding: Rising Star Award from Prostate Cancer Canada Continuously funded by Canadian Institutes of Health Research (CIHR) grants since 2005 Dr. Dong supervises graduate students in UBC's Cell and Developmental Biology, Experimental Medicine, and Interdisciplinary Oncology programs. His laboratory at the Vancouver Prostate Centre is dedicated to overcoming treatment resistance in prostate cancer.